WO1998006690B1 - USE OF η-HYDROXYBUTYRIC ACID AMIDES IN THE TREATMENT OF DRUG ADDICTION AND IN PARTICULAR OF ALCOHOLISM - Google Patents
USE OF η-HYDROXYBUTYRIC ACID AMIDES IN THE TREATMENT OF DRUG ADDICTION AND IN PARTICULAR OF ALCOHOLISMInfo
- Publication number
- WO1998006690B1 WO1998006690B1 PCT/EP1997/004309 EP9704309W WO9806690B1 WO 1998006690 B1 WO1998006690 B1 WO 1998006690B1 EP 9704309 W EP9704309 W EP 9704309W WO 9806690 B1 WO9806690 B1 WO 9806690B1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compound
- formula
- amide
- alcohol
- butyrolactone
- Prior art date
Links
- 150000001408 amides Chemical class 0.000 title claims abstract 8
- 208000007848 Alcoholism Diseases 0.000 title abstract 2
- 206010013663 Drug dependence Diseases 0.000 title abstract 2
- 201000007930 alcohol dependence Diseases 0.000 title abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract 5
- 150000001875 compounds Chemical class 0.000 claims 9
- -1 CH3 compound Chemical group 0.000 claims 7
- 238000000034 method Methods 0.000 claims 5
- YEJRWHAVMIAJKC-UHFFFAOYSA-N γ-lactone 4-hydroxy-butyric acid Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 claims 4
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims 3
- 239000002904 solvent Substances 0.000 claims 3
- 239000003377 acid catalyst Substances 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 150000001412 amines Chemical class 0.000 claims 2
- 239000003054 catalyst Substances 0.000 claims 2
- 150000002148 esters Chemical class 0.000 claims 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 230000000875 corresponding Effects 0.000 claims 1
- 150000007522 mineralic acids Chemical class 0.000 claims 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 239000000758 substrate Substances 0.000 claims 1
- 235000011149 sulphuric acid Nutrition 0.000 claims 1
- 239000001117 sulphuric acid Substances 0.000 claims 1
- SJZRECIVHVDYJC-UHFFFAOYSA-M 4-hydroxybutyrate Chemical compound OCCCC([O-])=O SJZRECIVHVDYJC-UHFFFAOYSA-M 0.000 abstract 1
- 229940120060 Heroin Drugs 0.000 abstract 1
- GVGLGOZIDCSQPN-PVHGPHFFSA-N Heroin Chemical compound O([C@H]1[C@H](C=C[C@H]23)OC(C)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4OC(C)=O GVGLGOZIDCSQPN-PVHGPHFFSA-N 0.000 abstract 1
- BQJCRHHNABKAKU-KBQPJGBKSA-N Morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 abstract 1
- 230000001476 alcoholic Effects 0.000 abstract 1
- 235000013334 alcoholic beverage Nutrition 0.000 abstract 1
- 230000001684 chronic Effects 0.000 abstract 1
- 229960002069 diamorphine Drugs 0.000 abstract 1
- 229960005181 morphine Drugs 0.000 abstract 1
- 229930014694 morphine Natural products 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 201000010874 syndrome Diseases 0.000 abstract 1
Abstract
The present invention relates to the use of η-hydroxybutyric acid amides, herein referred to as GHB, in the treatment of drug addiction, such as heroin, morphine and psychoactive substances and in the treatment of alcoholism, more particularly in reducing chronic alcoholics' desire for and habit of consuming alcoholic drinks and in the treatment of the syndrome of abstinence from alcohol.
Claims
AMENDED CLAIMS
[received by the International Bureau on 9 March 1998 (09.03.98); original claims 24-33 replaced by amended claims 24-32; remaining claims unchanged (3 pages)]
- and the amide of group c) is compound 16) of formula (I), in which Q=CH3, T^T^H, n=1 , R^phenyl, R2=H. 24. The composition as claimed in claim 23, wherein the amide is selected from compound 5), 7), 14) and compound 15). 25. The composition as claimed in claim 18 to be administered by the oral or parenteral way. 26. Amide of formula (I) Q I R20-(CH2),-CO-N-CCT1TJπ-R1 (I) where Q=H, T^T^H, n=1 , R^ethyl, R2=H compound 2); where Q=H, T^T^H, n=1 , R1=4-methylphenyl, R2=CH3 compound 7) where Q=H, T1=T2=H, n=1 , R^S.δ-dimethoxyphenyl, R2=H compound 8); where Q=H, T,=T2=H, n=1 , R^-pyridyl, R2=H compound 9); where Q=H, T^T^H, n=1 , R^phenyl, R2=CH3 compound 10); where Q=H, T1=T2=H, n=1 , R1=4-chlorophenyl, R2=CH3 compound 11 ); where Q=H, T^T^H, n=1 , R1=4-methylphenyl, R2=CH3CH2- compound 12); where Q=H, T^T^H, n=1 , R1=4-methylphenyl, R2=CH3CH2CH2- compound 13); where Q=H, T^T^H, n=1 , R^l-naphthyl, R2=CH3 compound 14); where Q=H, T1=T2=Hf n=1 , R1=4-CF3-phenyl, R2=CH3 compound 15); where Q=CH3, T^T^H, n=1 , R^phenyl, R2=H compound 16). 27. The amide as claimed in claim 26, selected from compound 7) and compound 14). 28. Process for the preparation of an amide of formula (I) Q
where R2 is an alkyl and the other substituents are as defined in claim 1 , comprising the following steps: a) treating γ-butyrolactone with an alcohol of formula R2OH (III) in which R2 is an alkyl, in the presence of an ortho-formiate of formula (IV)
34
H-C(OR2)3 (IV) in which R2 is as defined above for the alcohol of formula (III), in the presence of an acid catalyst, to give an ester of formula (V) R20-(CH2)3-COOR2 (V) in which R2 is as defined above for the alcohol of formula (III); b) treating the ester of formula (V) obtained in a) with an amine of formula (VI) Q I H-N-tCT ^-R, (VI) where R1 f Q, T1 ( T2, and n are as defined above for formula (I), in the presence of an ammonium halide. 29. The process as claimed in claim 28, wherein R2 is C1-C3 alkyl. 30. The process as claimed in claim 28, wherein step a) utilizes ortho-formiate in a quantity of 1.5-2 mol per mol γ-butyrolactone, an alcohol of formula (III) as solvent; an acid catalyst consisting of an inorganic acid in a quantity of 0.05-0.5 equivalent in respect of γ-butyrolactone, a reaction temperature ranging from 30°C to 100°C; step b) is carried out in the absence of solvent, at a temperature ranging from 100°C to 200°C, at a pressure ranging from atmospheric to autogenous pressure (obtained by operating in a bomb), with ammonium halide in a quantity ranging from 0.01 to 0.1 equivalent in respect of the substrate. 31. The process as claimed in claim 28, wherein step a) is carried out with a catalyst consisting of sulphuric acid in a quantity of 0.1 equivalent, at a temperature ranging from +50°C to +80°C; in step b) the catalyst is NH4CI, the temperature is 160°C to 170°C, and the reaction is carried out in a bomb. 32. Process for the preparation of an amide of formula (l)B Q I HO-(CH2)3-CO-N-[CT1T2]n-R1 (l)B in which R, is an aromatic heterocycle, and Q, T1 f T2 and n are as defined for formula (I) in claim 1 , in which γ-butyrolactone reacted with the corresponding amine of formula (II)
Q I H-N-fCT Jn-R, (II)
in which R1( Q, T1t T2 and n are as defined above, by contacting the reagents in equimolar amounts in the absence of solvent at a temperature ranging from 100°C to 200°C, at atmospheric pressure.
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK97941921T DK0932597T3 (en) | 1996-08-09 | 1997-08-07 | Use of gamma-hydroxybutyric acid amides for the treatment of drug dependence and especially alcoholism |
AT97941921T ATE215065T1 (en) | 1996-08-09 | 1997-08-07 | USE OF GAMMA-HYDROXYBUTTERIC AMIDES IN THE TREATMENT OF DRUG DEPENDENCE AND ESPECIALLY ALCOHOLISM |
SI9730343T SI0932597T1 (en) | 1996-08-09 | 1997-08-07 | Use of gamma-hydroxybutyric acid amides in the treatment of drug addiction and in particular of alcoholism |
CA002263328A CA2263328C (en) | 1996-08-09 | 1997-08-07 | Use of .gamma.-hydroxybutyric acid amides in the treatment of drug addiction and in particular of alcoholism |
JP50937298A JP4259615B2 (en) | 1996-08-09 | 1997-08-07 | Use of .GAMMA.-hydroxybutyric acid amide in drug use and especially in alcoholic dormitories. |
US09/242,048 US6436998B1 (en) | 1996-08-09 | 1997-08-07 | Use of gamma-hydroxybutyric acid amides in the treatment of drug addiction and in particular of alcoholism |
EP97941921A EP0932597B1 (en) | 1996-08-09 | 1997-08-07 | Use of gamma-hydroxybutyric acid amides in the treatment of drug addiction and in particular of alcoholism |
DE69711411T DE69711411T2 (en) | 1996-08-09 | 1997-08-07 | USE OF GAMMA HYDROXYBUTTERIC ACID AMIDES IN THE TREATMENT OF DRUG ADDICTION AND ESPECIALLY ALCOHOLISM |
AU43790/97A AU4379097A (en) | 1996-08-09 | 1997-08-07 | Use of gamma-hydroxybutyric acid amides in the treatment of drug addiction and in particular of alcoholism |
HU9902437A HU228595B1 (en) | 1996-08-09 | 1997-08-07 | Gamma-hydroxybutyric acid amides, process to prepare them, use gamma-hydroxybutyric acid amides, and pharmaceuticals contg. them for the treatmant of drug abusing |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI96A001732 | 1996-08-09 | ||
IT96MI001732A IT1283782B1 (en) | 1996-08-09 | 1996-08-09 | USE OF AMIDES OF GAMMA-HYDROXYBUTYRIC ACID IN THE TREATMENT OF TOXIC ADDICTION, AND IN PARTICULAR IN ALCOHOLISM |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/013,971 Division US6770784B2 (en) | 1996-08-09 | 2001-12-11 | Use of γ-hydroxybutyric acid amides in the treatment of drug addiction and in particular of alcoholism |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1998006690A1 WO1998006690A1 (en) | 1998-02-19 |
WO1998006690B1 true WO1998006690B1 (en) | 1998-04-16 |
Family
ID=11374795
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1997/004309 WO1998006690A1 (en) | 1996-08-09 | 1997-08-07 | USE OF η-HYDROXYBUTYRIC ACID AMIDES IN THE TREATMENT OF DRUG ADDICTION AND IN PARTICULAR OF ALCOHOLISM |
Country Status (13)
Country | Link |
---|---|
US (2) | US6436998B1 (en) |
EP (1) | EP0932597B1 (en) |
JP (1) | JP4259615B2 (en) |
AT (1) | ATE215065T1 (en) |
AU (1) | AU4379097A (en) |
CA (1) | CA2263328C (en) |
DE (1) | DE69711411T2 (en) |
DK (1) | DK0932597T3 (en) |
ES (1) | ES2174287T3 (en) |
HU (1) | HU228595B1 (en) |
IT (1) | IT1283782B1 (en) |
PT (1) | PT932597E (en) |
WO (1) | WO1998006690A1 (en) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000038672A2 (en) * | 1998-12-23 | 2000-07-06 | Orphan Medical, Inc. | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
FR2827859B1 (en) | 2001-07-30 | 2005-09-23 | Lipha | 4- (ARYLTHIO) - OR 4- (HETEROARYLTHIO) -BUTYRIC DERIVATIVES IN THE PREPARATION OF MEDICINES FOR THE TREATMENT OF DIABETES |
AU2003295393A1 (en) * | 2002-11-01 | 2004-06-07 | Baylor Research Institute | Ghb treatment methods |
US7838556B2 (en) * | 2006-02-21 | 2010-11-23 | University Of Maryland, Baltimore | Ethers of 3-hydroxyphenylacetic acid as selective gamma-hydroxybutyric acid receptor ligands |
EP2062875A1 (en) * | 2007-11-13 | 2009-05-27 | LABORATORIO FARMACEUTICO C.T. S.r.l. | New polymorphic forms of n-[4-(trifluoromethyl)benzyl]-4-methoxybutyramide |
US8778398B2 (en) * | 2008-11-04 | 2014-07-15 | Jazz Pharmaceuticals, Inc. | Immediate release formulations and dosage forms of gamma-hydroxybutyrate |
US8771735B2 (en) * | 2008-11-04 | 2014-07-08 | Jazz Pharmaceuticals, Inc. | Immediate release dosage forms of sodium oxybate |
BR112012024019B1 (en) | 2010-03-24 | 2021-10-19 | Jazz Phamaceuticals, Inc | CONTROLLED RELEASE DOSAGE FORM FOR ORAL ADMINISTRATION |
US8591922B1 (en) | 2012-12-14 | 2013-11-26 | Jazz Pharmacuticals, Inc. | Gamma-hydroxybutyrate compositions and their use for the treatment of disorders |
ITMI20132041A1 (en) * | 2013-12-06 | 2015-06-07 | Ct Lab Farm Srl | DERIVATIVES OF THE ACID RANGE-HYDROXYBUTIRRIC, THEIR PREPARATION AND THEIR MEDICAL USE. |
US10398662B1 (en) | 2015-02-18 | 2019-09-03 | Jazz Pharma Ireland Limited | GHB formulation and method for its manufacture |
ITUB20152860A1 (en) | 2015-08-04 | 2017-02-04 | Laboratorio Farm C T S R L | Selected amide of? -Hydroxybutyric acid and its uses in the treatment of alcohol abuse |
ITUA20164040A1 (en) * | 2016-06-01 | 2017-12-01 | Laboratorio Farm C T S R L | PROCEDURE FOR THE PREPARATION OF POLIMORFO A |
US11602512B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11602513B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11986451B1 (en) | 2016-07-22 | 2024-05-21 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
UY37341A (en) | 2016-07-22 | 2017-11-30 | Flamel Ireland Ltd | FORMULATIONS OF GAMMA-MODIFIED RELEASE HYDROXIBUTIRATE WITH IMPROVED PHARMACOCINETICS |
US11504347B1 (en) | 2016-07-22 | 2022-11-22 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US20180263936A1 (en) | 2017-03-17 | 2018-09-20 | Jazz Pharmaceuticals Ireland Limited | Gamma-hydroxybutyrate compositions and their use for the treatment of disorders |
KR20210094513A (en) | 2018-11-19 | 2021-07-29 | 재즈 파마슈티칼즈 아일랜드 리미티드 | Alcohol-Resistant Drug Formulations |
JP7553453B2 (en) | 2019-03-01 | 2024-09-18 | フラメル アイルランド リミテッド | Gamma-hydroxybutyrate compositions with improved pharmacokinetics under fed conditions - Patents.com |
WO2023126076A1 (en) | 2022-01-03 | 2023-07-06 | Laboratorio Farmaceutico C.T. S.R.L. | Medical use of an amide of y-hydroxybutyric acid in the treatment of fragile x syndrome |
US11779557B1 (en) | 2022-02-07 | 2023-10-10 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11583510B1 (en) | 2022-02-07 | 2023-02-21 | Flamel Ireland Limited | Methods of administering gamma hydroxybutyrate formulations after a high-fat meal |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3940258A (en) * | 1971-11-26 | 1976-02-24 | Gaf Corporation | Method for controlling aquatic weeds with N-phenylalkyl-γ-hydroxybutyramide |
JPS6016432B2 (en) * | 1977-07-26 | 1985-04-25 | グレラン製薬株式会社 | Heterocyclic compounds and their production methods |
ES2052619T3 (en) * | 1987-02-23 | 1994-07-16 | Ono Pharmaceutical Co | A PROCEDURE FOR THE PREPARATION OF THE NEW THIAZOLIDINE DERIVATIVES. |
IT1217783B (en) | 1988-06-03 | 1990-03-30 | Farmaceutico Ct S R L Lab | USE OF SALO DELL, BUTYRIC HYDROXIC ACID RANGE FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS SUITABLE FOR USE IN THE ALCOHOLIC THERAPY AND RELATED COMPOSITIONS |
IT1248588B (en) | 1991-06-28 | 1995-01-19 | Gaetano Crepaldi | PHARMACEUTICAL COMPOSITIONS FOR THERAPY OF ABSTINENCE, "CRAVING", DEPENDENCE ON AMAZING SUBSTANCES, PSYCHOACTIVE SUBSTANCES, NICOTINE AND FOOD DISORDERS. |
EP0763016B1 (en) * | 1994-06-01 | 2000-01-26 | Axys Pharmaceuticals, Inc. | Compositions and methods for treating mast-cell mediated conditions |
CZ272296A3 (en) * | 1995-09-18 | 1997-04-16 | Sankyo Co | Novel derivatives of urea exhibiting acat inhibition activity, their preparation and therapeutic and prophylactic application |
ES2237850T3 (en) * | 1997-10-14 | 2005-08-01 | Mitsubishi Pharma Corporation | PIPERAZINE COMPOUNDS AND THEIR MEDICINAL USE. |
-
1996
- 1996-08-09 IT IT96MI001732A patent/IT1283782B1/en active IP Right Grant
-
1997
- 1997-08-07 AU AU43790/97A patent/AU4379097A/en not_active Abandoned
- 1997-08-07 EP EP97941921A patent/EP0932597B1/en not_active Expired - Lifetime
- 1997-08-07 WO PCT/EP1997/004309 patent/WO1998006690A1/en active IP Right Grant
- 1997-08-07 US US09/242,048 patent/US6436998B1/en not_active Expired - Lifetime
- 1997-08-07 JP JP50937298A patent/JP4259615B2/en not_active Expired - Lifetime
- 1997-08-07 CA CA002263328A patent/CA2263328C/en not_active Expired - Lifetime
- 1997-08-07 DK DK97941921T patent/DK0932597T3/en active
- 1997-08-07 HU HU9902437A patent/HU228595B1/en unknown
- 1997-08-07 PT PT97941921T patent/PT932597E/en unknown
- 1997-08-07 AT AT97941921T patent/ATE215065T1/en active
- 1997-08-07 DE DE69711411T patent/DE69711411T2/en not_active Expired - Lifetime
- 1997-08-07 ES ES97941921T patent/ES2174287T3/en not_active Expired - Lifetime
-
2001
- 2001-12-11 US US10/013,971 patent/US6770784B2/en not_active Expired - Lifetime
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1998006690B1 (en) | USE OF η-HYDROXYBUTYRIC ACID AMIDES IN THE TREATMENT OF DRUG ADDICTION AND IN PARTICULAR OF ALCOHOLISM | |
EP1062999A3 (en) | Method for removing carbon dioxide from combustion exhaust gas | |
SK81599A3 (en) | Process to prepare tolterodine | |
DE19882892T1 (en) | Preparation of 3-substituted adenines and imidazopyridines | |
KR880012526A (en) | l-phenyl-3-naphthalenyloxypropanamine | |
KR950032058A (en) | Continuous production method of pure acrylic acid | |
RU97102150A (en) | METHOD FOR PRODUCING 2-HYDROXY-4-METHYLBUT OTHER ACID (METHIONINE HYDROXYANALOGUE, GAM), GAM AND ITS APPLICATION | |
WO1994020463B1 (en) | Novel distamycin analogues | |
WO1999003817B1 (en) | Aliphatic propargylamines as cellular rescue agents | |
WO2000033839B1 (en) | Non-peptide antagonists of glp-1 receptor and methods of use | |
ATE165810T1 (en) | N-SUBSTITUTED DERIVATIVES OF N-METHYL-3-(P-TRIFLUORMETHYLPHENOXY)-3-PHENYLPROPYLAMIN AND METHOD FOR THE PRODUCTION THEREOF | |
DE69803537D1 (en) | Continuous process for the production of diazomethane | |
CN1361102A (en) | Method of producing imidacloprid | |
NZ521201A (en) | Method for the preparation of citalopram | |
WO2006103696B1 (en) | Process for preparing levetiracetam and racemization of (r)- and (s)-2-amino butynamide and the corresponding acid derivatives | |
CA2469783A1 (en) | A method for preparing a sensitised emulsion explosive | |
EP0860417A3 (en) | Liquid crystalline compounds and process for producing the same | |
KR970074748A (en) | Process for preparing 3-amino substituted crotonate | |
KR900000349A (en) | Phenothiazine, a process for its preparation and a composition comprising the same | |
WO2003036257A3 (en) | Immobilizing biological molecules | |
RU2036910C1 (en) | Method of synthesis of 2-piperazinones | |
KR860003231A (en) | Method for preparing 2-cyanobenz imidazole derivative | |
WO2002000625A3 (en) | Process for the preparation of quinoline derivatives | |
RU96100855A (en) | METHOD OF OBTAINING 5-SUBSTITUTED 2-CHLORPYRIDINE | |
US11247167B2 (en) | Scavenging system including at least one mixed acetal compound to remove hydrogen sulfide and/or mercaptans from a fluid stream |